Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
240.70Prev. Close
239.85Volume
2,97,161Total traded value
7.08 CrUpper Circuit
285.95Lower Circuit
190.65Fundamentals
| Market Cap | ₹2,959Cr |
| ROE | 7.19% |
| P/E Ratio(TTM) | 46.77 |
| EPS(TTM) | 5.13 |
| P/B Ratio | 2.34 |
| Dividend Yield | 0.33% |
| Industry P/E | 35.07 |
| Book Value | 102.37 |
| Debt to Equity | 0.61 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Hikal
Hikal is a trusted partner for global pharmaceutical and crop protection companies, offering customised chemistry solutions while upholding high quality and regulatory standards. Its vision is to become the leading global fine chemical company across the pharmaceutical, crop protection, and specialty chemical industries. The company's Panoli API facility passed a US FDA audit with 'No Action Indicated', highlighting its commitment to global compliance.;
| Parent Organisation | Hikal Limited |
| Managing Director | Mr. Sameer Hiremath |
| NSE Symbol | HIKAL |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 75.45 | ||
| Neuland Laboratories | NA (0.00%) | 118.92 | ||
| Jubilant Pharmova | NA (0.00%) | 38.23 | ||
| Acutaas Chemicals | NA (0.00%) | 64.32 |